BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 973997)

  • 1. Macrophages and lymphoid tissues in mice with concomitant tumour immunity.
    Nelson DS; Kearney R
    Br J Cancer; 1976 Sep; 34(3):221-6. PubMed ID: 973997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of immunity to tumour isografts by the systemic administration of xenogeneic "immune" RNA.
    Deckers PJ; Pilch YH
    Nat New Biol; 1971 Jun; 231(23):181-3. PubMed ID: 5281197
    [No Abstract]   [Full Text] [Related]  

  • 3. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ; Focan C; Boniver J; Betz EH
    Pathol Eur; 1975; 10(4):317-25. PubMed ID: 1208123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-cell cytotoxic activity in the spleen and lymph nodes of tumour-bearing mice.
    Calder EA; Irvine WJ; Ghaffer A
    Clin Exp Immunol; 1975 Feb; 19(2):393-7. PubMed ID: 1212806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS; Pendergrast WJ; Myers GH
    Surg Forum; 1972; 23(0):101-2. PubMed ID: 4671039
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in spleen morphology and lymphoid cell activity during tumor progression.
    Yamagishi H; Pellis NR; Macek C; Kahan BD
    Eur J Cancer (1965); 1980 Nov; 16(11):1417-26. PubMed ID: 7227418
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice.
    James K; Milne I; Warr G
    Clin Exp Immunol; 1974 Oct; 18(2):243-50. PubMed ID: 4468197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
    Chang RW; Turk JL
    Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.
    Alexander P; Bensted J; Delorme EJ; Hall JG; Hodgett J
    Proc R Soc Lond B Biol Sci; 1969 Nov; 174(1035):237-51. PubMed ID: 4391182
    [No Abstract]   [Full Text] [Related]  

  • 11. Spleen weight in rats during tumour growth and in homograft rejection.
    Blamey RW; Evans DM
    Br J Cancer; 1971 Sep; 25(3):527-32. PubMed ID: 4947347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice.
    Kearney R; Harrop P
    Br J Cancer; 1980 Oct; 42(4):559-67. PubMed ID: 7002195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
    Kitano M; Okada Y
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adoptive transfer of concomitant immunity to murine tumor isografts with spleen cells from tumor-bearing animals.
    Deckers PJ; Edgerton BW; Thomas BS; Pilch YH
    Cancer Res; 1971 Jun; 31(6):734-42. PubMed ID: 5088484
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata.
    Currie GA; Eccles SA
    Br J Cancer; 1976 Jan; 33(1):51-9. PubMed ID: 766806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castration effects on tumor specific immunity.
    Brannen GE; Gomolka DM; Wettlaufer JN; Modarelli RO
    Invest Urol; 1977 Jul; 15(1):28-38. PubMed ID: 873734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
    Nelson M; Nelson DS
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):211-23. PubMed ID: 209776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.